Moderna to apply for authorization of Covid-19 vaccine in US, EU 

DPA, 30TH NOVEMBER, 2020- US firm Moderna said it will apply for emergency use authorization from the US Food and Drug Administration and conditional approval from the European Medicines Agency.

The company plans to submit the necessary applications for approval of the use of its Covid-19 vaccine in the United States and European Union on Monday, it said in a statement.

Moderna says it has already initiated so-called rolling review processes with the EMA, as well as regulatory authorities in Canada, Switzerland, Britain, Israel and Singapore, aimed at speeding up authorization.